Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
06/1993
06/15/1993US5219882 Treatment methods for lymes disease and associated debilitating conditions
06/15/1993US5219880 Treatment of viral tumors and hemorrhoids with artemisinin and derivatives
06/15/1993US5219879 Heterocyclic steroid compounds
06/15/1993US5219877 Fungicide. antiinflammatory agents
06/15/1993US5219874 Thromboxane synthetase inhibitors
06/15/1993US5219872 Treating Alzheimer*s disease, memory disorders
06/15/1993US5219871 Muscarinic receptor antagonists
06/15/1993US5219870 Antiulcer agents
06/15/1993US5219866 Antitumor agents
06/15/1993US5219865 Pharmaceutical combination for the prophylaxis and therapy of malaria
06/15/1993US5219864 Thienopyridine derivatives
06/15/1993US5219863 Angiotensin ii antagonizing compounds containing a 1,5-naphthyridine or a quinoline moiety
06/15/1993US5219862 Dopaminergic agents
06/15/1993US5219860 Spirocyclic antipsychotic agents
06/15/1993US5219859 Indole derivatives, preparation processes and medicinal products containing them
06/15/1993US5219858 Treating with ergotamine and caffeine salts, cocaine, amphetamines, nicotine therapy
06/15/1993US5219855 Anxiolytic drug
06/15/1993US5219854 Administering 3/2H/-pyridazinone compound
06/15/1993US5219853 Water miscible concentrated basic solution of active agent in propylene glycol or polyethylene glycol with triethanolamine or arginine
06/15/1993US5219849 Substituted pyrazines, pyrimidines and pyridazines for use in the treatment of glaucoma
06/15/1993US5219848 Cephem compounds
06/15/1993US5219847 Antipruritic composition
06/15/1993US5219846 Treatment of human tumors utilizing compounds having a phosphoamides linkage or enol phosphate linkage
06/15/1993US5219844 Combination of perfluorocarbon liquid and silicone and method of treating disorders of an eye with the combination
06/15/1993US5219841 Diadenosine 5', 5'''-p1, p4-tetraphosphate
06/15/1993US5219749 Process for isolating and preparing purified chitin deacetylase
06/15/1993US5219736 Process for producing 3-deacylated derivative of 16-membered macrolide antibiotic
06/15/1993US5219621 Methods of treatment with diltiazem formulations
06/15/1993US5219577 Biologically active composition having a nanocrystalline core
06/15/1993US5219573 L-sugar laxatives
06/15/1993US5219570 Laxatives; maltodetrin coating
06/15/1993US5219563 Contacting synthetic cation exchange resin with ranitidine or salt to form complex
06/15/1993US5219548 Used for selectively binding estrogen receptors of a tissue
06/15/1993US5219358 Shape memory effect surgical needles
06/15/1993CA2085200A1 Pharmaceutical composition
06/15/1993CA2085166A1 Ethanol adducts of 6-sulfonyl-substituted 3-hydroxychromans and their use as inhalants in diseases
06/15/1993CA1319151C2 ¬¬(3-pyridinyl)methylene|amino|alcohols
06/15/1993CA1319149C Pharmacologically active 2-and 3-substituted (1',5'-diaryl-3-pyrazolyl)-n-hydroxypropanamides and method for synthesizing the same
06/15/1993CA1319148C Thyronine analogous compounds
06/15/1993CA1319145C Substituted 3-piperidinamines or 3-azepinamines, the preparation thereof and their applications in therapy
06/15/1993CA1319144C Tetrahydronaphthalene derivatives
06/15/1993CA1319143C Antiviral compounds
06/15/1993CA1319111C Anti-acne composition
06/15/1993CA1319110C Pharmaceutical composition comprising exifone and water-soluble polymer
06/15/1993CA1319109C Spray dried ibuprofen
06/15/1993CA1319108C Drug delivery devices
06/15/1993CA1319107C Formulations for inhibiting glucose transport
06/15/1993CA1319106C Antacid composition
06/15/1993CA1319105C Antifungal gel formulations
06/15/1993CA1319099C Atriopeptins, guanylate cyclase activators, and phosphodiesterase inhibitors as treatment for glaucoma, hydrocephalus and cerebral edema (cranial fluid volume dysfunction)
06/14/1993WO1993012119A1 Thiadiazine carboxylic acid amide derivatives, methods of preparing them and drugs containing them
06/14/1993CA2103891A1 Thiadiazinecarboxamide derivatives, processes for their preparation and pharmaceuticals
06/14/1993CA2085212A1 Nutritive composition for prevention and therapy of infection diseases caused by immunosuppression
06/13/1993WO1993012128A1 DERIVATIVES OF 9-(β-D-XYLOFURANNOSYL)ADENINE AND OF 1-(β-D-XYLOFURANNOSYL)CYTOSINE, PREPARATION THEREOF AND APPLICATION IN THERAPEUTICS
06/13/1993WO1993011776A1 Method for inhibiting selectin-dependent adhesion of leukocytes and platelets by o-glycosylation modification
06/13/1993CA2124565A1 Method for inhibiting selectin-dependent adhesion of leukocytes and platelets by o-glycosylation modification
06/13/1993CA2103884A1 9-(b-d-xylofuranosyl)adenine and 1-(b-d-xylofuranosyl)cytosine derivatives, and preparation and therapeutic application thereof
06/13/1993CA2085215A1 Process for the preparation of a pharmaceutical composition selectively lowering the blood lipid level
06/13/1993CA2085137A1 New cephalosporins comprising a 7-substituted benzyloxyimino group, process of preparation thereof, their application as medication
06/12/1993CA2085046A1 Use of xanthine derivatives for stabilizing autoregulation of cerebral circulation
06/11/1993CA2084962A1 Pharmaceutical composition for the improvement of dysuria
06/11/1993CA2084470A1 Antitumor compositions and methods of treatment
06/10/1993WO1993011280A1 Multiple solvent cleaning system
06/10/1993WO1993011267A1 Antiviral agent comprising antisense oligonucleotides complementary to the bhrf1 gene of epstein-barr virus
06/10/1993WO1993011217A1 Hiv-destroying antiseptic solid, liquid or gelled soap
06/10/1993WO1993011145A1 Indolopyrrolocarbazole derivatives
06/10/1993WO1993011140A1 Antiviral compositions and method for their use
06/10/1993WO1993011136A1 New pyrrolidine derivatives
06/10/1993WO1993011133A1 [3H,7H]THIAZOLE[3,4-a]PYRIDINES HAVING ANTIASTHMATIC AND ANTIINFLAMMATORY ACTIVITIES ON THE RESPIRATORY TRACT
06/10/1993WO1993011131A1 Cephalosporin compounds
06/10/1993WO1993011130A1 Rapamycin derivative and its medicinal use
06/10/1993WO1993011129A1 Antiparasitic agents
06/10/1993WO1993011126A1 1'-amino-2-[(benzothiazolyl)methyl]spiro [isoquinoline-4(1h),3'-pyrrolidine]-1,2',3,5'(2h)-tetrones and analogs thereof useful as aldose reductase inhibitors
06/10/1993WO1993011122A1 Piperazine derivatives as 5-ht1a antagonists
06/10/1993WO1993011116A1 Novel azepine derivative, production thereof, and use thereof
06/10/1993WO1993011115A2 Quinolone derivatives and their use as nmda and ampa receptor antagonists
06/10/1993WO1993011110A1 Preparation of substituted piperidines
06/10/1993WO1993011108A1 Piperidine derivative and medicine containing the same
06/10/1993WO1993011107A1 Novel n-hydroxyalkyl-substituted 1,2,3,6-tetrahydropyridine and piperidine derivatives
06/10/1993WO1993011106A1 Indole derivatives
06/10/1993WO1993011105A1 Leukotriene-b4 derivatives, process for preparing the same and medicaments
06/10/1993WO1993011104A1 Organic salts of n, n'-diacetyl cystine
06/10/1993WO1993011101A1 Derivatives of arylsulphoacids having hypoglycemic activity
06/10/1993WO1993011099A1 Nitroaniline derivatives and their use as antitumor agents
06/10/1993WO1993011098A1 Fluorinated compounds as oxygen transport agents
06/10/1993WO1993010847A1 Method of reducing medical device related infections
06/10/1993WO1993010820A1 Enhanced triple-helix and double-helix formation with oligomers containing modified pyrimidines
06/10/1993WO1993010817A1 CDw52-SPECIFIC ANTIBODY FOR TREATMENT OF MULTIPLE SCLEROSIS
06/10/1993WO1993010802A1 Aqueous synthetic organ extracts
06/10/1993WO1993010797A1 Dimeticon pastilles
06/10/1993WO1993010796A1 Substituted lactose and lactosamine derivatives as cell adhesion inhibitors
06/10/1993WO1993010794A1 Composition and method for improving oral bioavailability of carbamazepine
06/10/1993WO1993010793A1 Antivirus agent
06/10/1993WO1993010792A1 Use of creatine phosphate or phosphoenolpyruvic acid for the treatment of tumours
06/10/1993WO1993010791A1 Use of a known chemical compound for the production of a pharmaceutical composition for topical application
06/10/1993WO1993010790A1 The use of ob-101 to treat inflammation
06/10/1993WO1993010789A1 The use of ob-104 to treat inflammation
06/10/1993WO1993010788A1 Methods and compositions for treating sleep disorders, convulsive seizures, and other disorders using optically pure (-) zopiclone
06/10/1993WO1993010787A1 Methods and compositions for treating sleep disorders, convulsive seizures, and other disorders using optically pure (+) zopiclone
06/10/1993WO1993010786A1 Methods and compositions for treating infection using optically pure (r)-lomefloxacin
1 ... 7186 7187 7188 7189 7190 7191 7192 7193 7194 7195 7196 7197 7198 7199 7200 7201 7202 7203 7204 7205 7206 ... 7860